Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ian M Thompson

Showing results (251-260 of 484) with videos related to

Pageof 49
Sort By:
JAMA Oncology|January 1, 2016
Adverse Health Events Following Intermittent and Continuous Androgen Deprivation in Patients With Metastatic Prostate CancerDawn L Hershman, Joseph M Unger, Jason D Wright, et al.
Journal of the National Cancer Institute|August 17, 2006
Effect of finasteride on the sensitivity of PSA for detecting prostate cancerIan M Thompson, Chen Chi, Donna Pauler Ankerst, et al.
JCO Oncology Practice|June 7, 2023
Crisis of the Clinical Trials Staff Attrition After the COVID-19 PandemicGrace Sun, Don S Dizon, Connie M Szczepanek, et al.
The New England Journal of Medicine|January 24, 2019
Long-Term Effects of Finasteride on Prostate Cancer MortalityPhyllis J Goodman, Catherine M Tangen, Amy K Darke, et al.
Carcinogenesis|June 12, 2008
CYP1B1 variants are associated with prostate cancer in non-Hispanic and Hispanic CaucasiansJoke Beuten, Jonathan A L Gelfond, John J Byrne, et al.
RSC Advances|June 23, 2015
Enhancement of performance in porous bead-based microchip sensors: Effects of chip geometry on bio-agent captureEliona Kulla, Jie Chou, Glennon Simmons, et al.
The Prostate|July 29, 2014
Nanomechanical biomarkers of single circulating tumor cells for detection of castration resistant prostate cancerPawel Osmulski, Devalingam Mahalingam, Maria E Gaczynska, et al.
Frontiers in Oncology|January 31, 2022
Associations Between Polymorphisms in Genes Related to Oxidative Stress and DNA Repair, Interactions With Serum Antioxidants, and Prostate Cancer Risk: Results From the Prostate Cancer Prevention TrialZhihong Gong, Mary E Platek, Cathee Till, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|November 6, 2009
Men with low serum cholesterol have a lower risk of high-grade prostate cancer in the placebo arm of the prostate cancer prevention trialElizabeth A Platz, Cathee Till, Phyllis J Goodman, et al.
Urology|February 22, 2011
Phase II evaluation of early oral estramustine, oral etoposide, and intravenous paclitaxel combined with hormonal therapy in patients with high-risk metastatic prostate adenocarcinoma: Southwest Oncology Group S0032David C Smith, Cathy M Tangen, Peter J Van Veldhuizen, et al.
Pageof 49

Showing results (251-260 of 484) with videos related to

Sort By:
Pageof 49
JAMA Oncology|January 1, 2016
Adverse Health Events Following Intermittent and Continuous Androgen Deprivation in Patients With Metastatic Prostate CancerDawn L Hershman, Joseph M Unger, Jason D Wright, et al.
Journal of the National Cancer Institute|August 17, 2006
Effect of finasteride on the sensitivity of PSA for detecting prostate cancerIan M Thompson, Chen Chi, Donna Pauler Ankerst, et al.
JCO Oncology Practice|June 7, 2023
Crisis of the Clinical Trials Staff Attrition After the COVID-19 PandemicGrace Sun, Don S Dizon, Connie M Szczepanek, et al.
The New England Journal of Medicine|January 24, 2019
Long-Term Effects of Finasteride on Prostate Cancer MortalityPhyllis J Goodman, Catherine M Tangen, Amy K Darke, et al.
Carcinogenesis|June 12, 2008
CYP1B1 variants are associated with prostate cancer in non-Hispanic and Hispanic CaucasiansJoke Beuten, Jonathan A L Gelfond, John J Byrne, et al.
RSC Advances|June 23, 2015
Enhancement of performance in porous bead-based microchip sensors: Effects of chip geometry on bio-agent captureEliona Kulla, Jie Chou, Glennon Simmons, et al.
The Prostate|July 29, 2014
Nanomechanical biomarkers of single circulating tumor cells for detection of castration resistant prostate cancerPawel Osmulski, Devalingam Mahalingam, Maria E Gaczynska, et al.
Frontiers in Oncology|January 31, 2022
Associations Between Polymorphisms in Genes Related to Oxidative Stress and DNA Repair, Interactions With Serum Antioxidants, and Prostate Cancer Risk: Results From the Prostate Cancer Prevention TrialZhihong Gong, Mary E Platek, Cathee Till, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|November 6, 2009
Men with low serum cholesterol have a lower risk of high-grade prostate cancer in the placebo arm of the prostate cancer prevention trialElizabeth A Platz, Cathee Till, Phyllis J Goodman, et al.
Urology|February 22, 2011
Phase II evaluation of early oral estramustine, oral etoposide, and intravenous paclitaxel combined with hormonal therapy in patients with high-risk metastatic prostate adenocarcinoma: Southwest Oncology Group S0032David C Smith, Cathy M Tangen, Peter J Van Veldhuizen, et al.
Pageof 49